APA (7th ed.) Citation

A, I., NM, B., PR, H. V., B, G., SR, S., A, P., . . . B, B. (2026). Next-generation hybrid bioanalytical platforms and clinical integration of TDM technologies for precision monitoring to optimize last-resort antibiotic therapy. Frontiers in pharmacology, 17, 1761582. https://doi.org/10.3389/fphar.2026.1761582

Chicago Style (17th ed.) Citation

A, Inamdar, et al. "Next-generation Hybrid Bioanalytical Platforms and Clinical Integration of TDM Technologies for Precision Monitoring to Optimize Last-resort Antibiotic Therapy." Frontiers in Pharmacology 17 (2026): 1761582. https://doi.org/10.3389/fphar.2026.1761582.

MLA (9th ed.) Citation

A, Inamdar, et al. "Next-generation Hybrid Bioanalytical Platforms and Clinical Integration of TDM Technologies for Precision Monitoring to Optimize Last-resort Antibiotic Therapy." Frontiers in Pharmacology, vol. 17, 2026, p. 1761582, https://doi.org/10.3389/fphar.2026.1761582.